Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx® and dry chemistry enzyme immunoassay on the Vitros 950
-
Bogdan Solnica
Abstract
The aim of the study was to compare the results of digoxin assays performed using fluorescence polarization immunoassay (FPIA) on the TDxFLx® and a dry chemistry enzyme immunoassay (EIA) on the Vitros 950. Within-run CV amounted to 8.52–10.49% for FPIA and 2.47–5.39% for EIA. Between-run CV amounted to 6.41–8.97% for FPIA and 3.40–5.04% for EIA. Analytical bias ranged from 2.57–4.0% for FPIA and from 9.86–11.9% for EIA. In comparative studies the correlation coefficient was 0.878; Deming regression analysis yielded a slope of 1.057 (95% CI: 0.573 to 1.541) and intercept of 0.078 (95% CI: –0.391 to 0.547), and the Passing-Bablok agreement test yielded a slope of 1.111 (95% CI: 0.988 to 1.212) and intercept of 0.094 (95% CI: –0.018 to 0.182). The mean digoxin concentration in patients’ sera measured by EIA was significantly higher than that measured by FPIA (1.347 vs. 1.196 ng/ml, p < 0.02). The mean absolute difference between results amounted to 0.146 ng/ml (95% CI: 0.0261 to 0.266). In comparison to EIA, FPIA yielded a higher number of subtherapeutic concentrations < 0.5 ng/ml (29.7% vs. 21.8%) and a lower number of digoxin concentrations > 1.2 ng/ml (25.7% vs. 35.6%). These discrepancies occurred in approximately 10% of samples. The obtained results showed different analytical performance and method-dependent differences in the distribution of results. This indicates the necessity to harmonize digoxin immunoassays if two different analytical systems are used in the same clinical setting.
References
1 Hallworth M, Capps N. Analytical aspects. In: Hallworth M, Capps N. Therapeutic drug monitoring & clinical biochemistry. London: ACB Venture Publications, 1993:95–120.Search in Google Scholar
2 Test Methodology Vitros DGXN Slides, Part No. MP2-114. In: Vitros test methodology manual. Rochester, NY: Johnson & Johnson Clinical Diagnostics, 1996.Search in Google Scholar
3 Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. J Clin Chem Clin Biochem 1983; 21:709–20.Search in Google Scholar
4 Stöckl D, Dewitte K, Thienpont LM. Validity of linear regression in method comparison studies: is it limited by the statistical model or the quality of the analytical input data? Clin Chem 1998; 44:2340–6.10.1093/clinchem/44.11.2340Search in Google Scholar
5 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307–10.Search in Google Scholar
6 Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. J Am Med Assoc 2003; 289:871–8.10.1001/jama.289.7.871Search in Google Scholar PubMed
7 Steele BW, Wang E, Palomski GE, Klee GG, Elin RJ, Soldin SJ, et al. An evaluation of analytic goals for assays of drugs. A College of American Pathologists Therapeutic Drug Monitoring Survey Study. Arch Pathol Lab Med 2001; 125:729–35.10.5858/2001-125-0729-AEOAGFSearch in Google Scholar PubMed
8 Valdes R Jr, Jortani SA, Gheorghiade M. Standards of laboratory practice: cardiac drug monitoring. Clin Chem 1998; 44:1096–109.10.1093/clinchem/44.5.1096Search in Google Scholar
9 Frezzotti A, Giordano G, Margarucci Gambini AM. Analytical performance of a monoclonal digoxin assay by dry chemistry on the Vitros 950. Scand J Clin Lab Invest 1999; 59:431–7.10.1080/00365519950185454Search in Google Scholar PubMed
10 De BK, Booth DD, Magee PJ, Moore ML, Preuss TM, Rose TA, Roberts WL. Analytic performance of two automated nonpretreatment digoxin immunoassays. Ther Drug Monit 1999; 21:123–8.10.1097/00007691-199902000-00019Search in Google Scholar PubMed
11 Ferreri LF, Raisys VA, Opheim KE. Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation. J Anal Toxicol 1984; 8:138–40.10.1093/jat/8.3.138Search in Google Scholar PubMed
12 Oeltgen PR, Shank WA Jr, Blouin RA, Clark T. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer. Ther Drug Monit 1984; 6:360–7.10.1097/00007691-198409000-00018Search in Google Scholar PubMed
13 Datta P, Xu L, Malik S, Landicho D, Ferreri L, Halverson K, et al. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups. Clin Chem 1996; 42:373–9.10.1093/clinchem/42.3.373Search in Google Scholar
14 Boscato LM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32:1491–5.10.1093/clinchem/32.8.1491Search in Google Scholar
15 Liendo C, Ghali JK, Graves SW. A new interference in some digoxin assays: anti-murine heterophilic antibodies. Clin Pharmacol Ther 1996; 60:593–8.10.1016/S0009-9236(96)90157-5Search in Google Scholar
16 Dasgupta A. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin. Am J Clin Pathol 2002; 118:132–40.10.1309/3VNP-TWFQ-HT9A-1QH8Search in Google Scholar PubMed
17 Ijiri Y, Hayashi T, Kamegai H, Ohi K, Suzuki K, Kitaura Y, et al. Digitalis-like immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay. Ther Drug Monit 2003; 25:234–9.10.1097/00007691-200304000-00015Search in Google Scholar PubMed
18 Steimer W, Müller C, Eber B. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids. Clin Chem 2002; 48:507–16.10.1093/clinchem/48.3.507Search in Google Scholar
19 Okazaki M, Tanigawara Y, Kita T, Komada F, Okumura K. Cross-reactivity of TDX and OPUS immunoassay systems for serum digoxin determination. Ther Drug Monit 1997; 19:657–62.10.1097/00007691-199712000-00009Search in Google Scholar PubMed
20 Kaiser P, Kramer U, Meissner D, Kress M, Wood WG, Reinauer H. Determination of the cardiac glycosides digoxin and digitoxin by liquid chromatography combined with isotope-dilution mass spectrometry (LCIDMS) – a candidate reference measurement procedure. Clin Lab 2003; 49:329–43.Search in Google Scholar
© Walter de Gruyter
Articles in the same Issue
- Rapid detection of the factor XIII Val34Leu (163 G→T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis
- Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with age and disease activity
- A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer
- N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias
- Preventing in vitro lipoperoxidation in the malondialdehyde-thiobarbituric assay
- Oxidative stress: potential of distinct peroxide determination systems
- Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance
- Guidelines for blood smear preparation and staining procedure for setting up an external quality assessment scheme for blood smear interpretation. Part I: control material
- Measurement of serum and plasma osmolality in healthy young humans – influence of time and storage conditions
- High in-hospital mortality of intensive care patients with nucleated red blood cells in blood
- Frequency of –163 C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations
- Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples
- Plasma or serum samples: measurements of cardiac troponin T and of other analytes compared
- Antioxidant capacity of the human pericardial fluid: does gender have a role?
- Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx® and dry chemistry enzyme immunoassay on the Vitros 950
- Multicenter analytical performance evaluation of the Elecsys® proBNP assay
- Analytical evaluation and reference values of serum amyloid-A on the BN ProSpec
- Reference values of soluble interleukin-2 receptor on the IMMULITE
- Analysis of cystatin C, creatinine, albumin, lipids and lipoprotein concentrations in serum and acidified citrate plasma (Stabilyte™) tubes compared
- Analysis of γ-globulins consisting of hepatitis C-associated cryoglobulins in the blood
- Serum total glutathione-S-transferase in stroke, a preliminary report
- Santorini Biologie Prospective Conference 2004 “From Human Genetic Variations to Prediction of Risks and Responses to the Environment”, Santorini, Greece, September 30–October 4, 2004
Articles in the same Issue
- Rapid detection of the factor XIII Val34Leu (163 G→T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis
- Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with age and disease activity
- A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer
- N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias
- Preventing in vitro lipoperoxidation in the malondialdehyde-thiobarbituric assay
- Oxidative stress: potential of distinct peroxide determination systems
- Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance
- Guidelines for blood smear preparation and staining procedure for setting up an external quality assessment scheme for blood smear interpretation. Part I: control material
- Measurement of serum and plasma osmolality in healthy young humans – influence of time and storage conditions
- High in-hospital mortality of intensive care patients with nucleated red blood cells in blood
- Frequency of –163 C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations
- Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples
- Plasma or serum samples: measurements of cardiac troponin T and of other analytes compared
- Antioxidant capacity of the human pericardial fluid: does gender have a role?
- Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx® and dry chemistry enzyme immunoassay on the Vitros 950
- Multicenter analytical performance evaluation of the Elecsys® proBNP assay
- Analytical evaluation and reference values of serum amyloid-A on the BN ProSpec
- Reference values of soluble interleukin-2 receptor on the IMMULITE
- Analysis of cystatin C, creatinine, albumin, lipids and lipoprotein concentrations in serum and acidified citrate plasma (Stabilyte™) tubes compared
- Analysis of γ-globulins consisting of hepatitis C-associated cryoglobulins in the blood
- Serum total glutathione-S-transferase in stroke, a preliminary report
- Santorini Biologie Prospective Conference 2004 “From Human Genetic Variations to Prediction of Risks and Responses to the Environment”, Santorini, Greece, September 30–October 4, 2004
